Moreover, p300 (a transcription co-activator) has been reported to participate in the transcription of COX-2 [30], whether p300 participates in the interaction between XRCC5 and COX-2 gene promoter in CRC also needs to be elucidated. This evidence concerns the gene EP300 and colorectal carcinoma.